The effect of hetastarch (670/0.75) on urine specific gravity and osmolality in the dog

L. Smart, Katrina Hopper, J. Aldrich, J. George, Philip H Kass, S. Haskins

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background: Urine specific gravity (USG) is used clinically to estimate urine osmolality (UOsm). Although USG has been shown to have a linear correlation with UOsm in dogs, the relationship is altered when there are significant numbers of high molecular weight (MW) molecules in the urine. Hypothesis: USG would no longer predict UOsm in dogs given intravenous hetastarch (670/0.75)(HES). Animals: Eight healthy employee-owned adult dogs. Methods: Prospective, controlled experimental study. USG and UOsm were measured every 30 minutes from t=0 minutes to t=360 minutes. Dogs were administered 20mL/kg of either NaCl 0.9% (control group, n=4) or HES (treatment group, n=8) IV over 1 hour starting at t=90 minutes. Results: There was a decrease in UOsm in both groups starting at t=120 minutes and continuing for the study duration, and there was no significant difference in UOsm between treatment and control groups across all time points. There was an appropriate decrease in USG from t=120 minutes for the control group. In the treatment group, USG increased significantly at t=120 minutes (P = .0006), t=150 minutes (P = .0002), and t=180 minutes (P = .0044). The largest increase in USG occurred at t=150 minutes with a mean USG of 1.070 ± 0.021 (range 1.038-1.104). Conclusions and clinical importance: Urine specific gravity should not be used to estimate urine solute concentration in dogs following the administration of 20mL/kg of HES. In a clinical setting, the evaluation of USG following this dose of HES may lead to an overestimation of urine concentration.

Original languageEnglish (US)
Pages (from-to)388-391
Number of pages4
JournalJournal of Veterinary Internal Medicine
Volume23
Issue number2
DOIs
StatePublished - Mar 2009

Fingerprint

Hydroxyethyl Starch Derivatives
Specific Gravity
osmolality
specific gravity
Osmolar Concentration
urine
Urine
Dogs
dogs
Control Groups

Keywords

  • Artificial colloid
  • Clinical pathology
  • Fluid therapy

ASJC Scopus subject areas

  • veterinary(all)

Cite this

The effect of hetastarch (670/0.75) on urine specific gravity and osmolality in the dog. / Smart, L.; Hopper, Katrina; Aldrich, J.; George, J.; Kass, Philip H; Haskins, S.

In: Journal of Veterinary Internal Medicine, Vol. 23, No. 2, 03.2009, p. 388-391.

Research output: Contribution to journalArticle

@article{81e0347cacb749ccaab54973fc7bbb61,
title = "The effect of hetastarch (670/0.75) on urine specific gravity and osmolality in the dog",
abstract = "Background: Urine specific gravity (USG) is used clinically to estimate urine osmolality (UOsm). Although USG has been shown to have a linear correlation with UOsm in dogs, the relationship is altered when there are significant numbers of high molecular weight (MW) molecules in the urine. Hypothesis: USG would no longer predict UOsm in dogs given intravenous hetastarch (670/0.75)(HES). Animals: Eight healthy employee-owned adult dogs. Methods: Prospective, controlled experimental study. USG and UOsm were measured every 30 minutes from t=0 minutes to t=360 minutes. Dogs were administered 20mL/kg of either NaCl 0.9{\%} (control group, n=4) or HES (treatment group, n=8) IV over 1 hour starting at t=90 minutes. Results: There was a decrease in UOsm in both groups starting at t=120 minutes and continuing for the study duration, and there was no significant difference in UOsm between treatment and control groups across all time points. There was an appropriate decrease in USG from t=120 minutes for the control group. In the treatment group, USG increased significantly at t=120 minutes (P = .0006), t=150 minutes (P = .0002), and t=180 minutes (P = .0044). The largest increase in USG occurred at t=150 minutes with a mean USG of 1.070 ± 0.021 (range 1.038-1.104). Conclusions and clinical importance: Urine specific gravity should not be used to estimate urine solute concentration in dogs following the administration of 20mL/kg of HES. In a clinical setting, the evaluation of USG following this dose of HES may lead to an overestimation of urine concentration.",
keywords = "Artificial colloid, Clinical pathology, Fluid therapy",
author = "L. Smart and Katrina Hopper and J. Aldrich and J. George and Kass, {Philip H} and S. Haskins",
year = "2009",
month = "3",
doi = "10.1111/j.1939-1676.2008.0252.x",
language = "English (US)",
volume = "23",
pages = "388--391",
journal = "Journal of Veterinary Internal Medicine",
issn = "0891-6640",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - The effect of hetastarch (670/0.75) on urine specific gravity and osmolality in the dog

AU - Smart, L.

AU - Hopper, Katrina

AU - Aldrich, J.

AU - George, J.

AU - Kass, Philip H

AU - Haskins, S.

PY - 2009/3

Y1 - 2009/3

N2 - Background: Urine specific gravity (USG) is used clinically to estimate urine osmolality (UOsm). Although USG has been shown to have a linear correlation with UOsm in dogs, the relationship is altered when there are significant numbers of high molecular weight (MW) molecules in the urine. Hypothesis: USG would no longer predict UOsm in dogs given intravenous hetastarch (670/0.75)(HES). Animals: Eight healthy employee-owned adult dogs. Methods: Prospective, controlled experimental study. USG and UOsm were measured every 30 minutes from t=0 minutes to t=360 minutes. Dogs were administered 20mL/kg of either NaCl 0.9% (control group, n=4) or HES (treatment group, n=8) IV over 1 hour starting at t=90 minutes. Results: There was a decrease in UOsm in both groups starting at t=120 minutes and continuing for the study duration, and there was no significant difference in UOsm between treatment and control groups across all time points. There was an appropriate decrease in USG from t=120 minutes for the control group. In the treatment group, USG increased significantly at t=120 minutes (P = .0006), t=150 minutes (P = .0002), and t=180 minutes (P = .0044). The largest increase in USG occurred at t=150 minutes with a mean USG of 1.070 ± 0.021 (range 1.038-1.104). Conclusions and clinical importance: Urine specific gravity should not be used to estimate urine solute concentration in dogs following the administration of 20mL/kg of HES. In a clinical setting, the evaluation of USG following this dose of HES may lead to an overestimation of urine concentration.

AB - Background: Urine specific gravity (USG) is used clinically to estimate urine osmolality (UOsm). Although USG has been shown to have a linear correlation with UOsm in dogs, the relationship is altered when there are significant numbers of high molecular weight (MW) molecules in the urine. Hypothesis: USG would no longer predict UOsm in dogs given intravenous hetastarch (670/0.75)(HES). Animals: Eight healthy employee-owned adult dogs. Methods: Prospective, controlled experimental study. USG and UOsm were measured every 30 minutes from t=0 minutes to t=360 minutes. Dogs were administered 20mL/kg of either NaCl 0.9% (control group, n=4) or HES (treatment group, n=8) IV over 1 hour starting at t=90 minutes. Results: There was a decrease in UOsm in both groups starting at t=120 minutes and continuing for the study duration, and there was no significant difference in UOsm between treatment and control groups across all time points. There was an appropriate decrease in USG from t=120 minutes for the control group. In the treatment group, USG increased significantly at t=120 minutes (P = .0006), t=150 minutes (P = .0002), and t=180 minutes (P = .0044). The largest increase in USG occurred at t=150 minutes with a mean USG of 1.070 ± 0.021 (range 1.038-1.104). Conclusions and clinical importance: Urine specific gravity should not be used to estimate urine solute concentration in dogs following the administration of 20mL/kg of HES. In a clinical setting, the evaluation of USG following this dose of HES may lead to an overestimation of urine concentration.

KW - Artificial colloid

KW - Clinical pathology

KW - Fluid therapy

UR - http://www.scopus.com/inward/record.url?scp=66149157833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149157833&partnerID=8YFLogxK

U2 - 10.1111/j.1939-1676.2008.0252.x

DO - 10.1111/j.1939-1676.2008.0252.x

M3 - Article

VL - 23

SP - 388

EP - 391

JO - Journal of Veterinary Internal Medicine

JF - Journal of Veterinary Internal Medicine

SN - 0891-6640

IS - 2

ER -